MaxCyte Inc. held its annual meeting of stockholders on June 18, 2025. During the meeting, the stockholders approved several key proposals. The election of Class I Directors was confirmed, with nominees Maher Masoud, Yasir Al-Wakeel, and Rekha Hemrajani being elected. An amendment to the 2022 Equity Incentive Plan was approved, increasing the number of shares authorized for issuance. The cancellation of the company's common stock trading on the AIM market of the London Stock Exchange was also approved. Additionally, the selection of CohnReznick LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. Lastly, the proposal to adjourn the meeting was rendered moot as all other proposals were passed.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.